| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DUF4599 | 1.75e-07 | 12 | 83 | 4 | PF15371 | |
| Domain | DUF4599 | 1.75e-07 | 12 | 83 | 4 | IPR027970 | |
| Domain | IRF1/IRF2 | 1.95e-05 | 2 | 83 | 2 | IPR017431 | |
| Domain | IRF | 6.88e-04 | 9 | 83 | 2 | SM00348 | |
| Domain | Interferon_reg_fact_DNA-bd_dom | 6.88e-04 | 9 | 83 | 2 | IPR001346 | |
| Domain | IRF | 6.88e-04 | 9 | 83 | 2 | PF00605 | |
| Domain | IRF_1 | 6.88e-04 | 9 | 83 | 2 | PS00601 | |
| Domain | Interferon_reg_fac_CS | 6.88e-04 | 9 | 83 | 2 | IPR019817 | |
| Domain | IRF_2 | 6.88e-04 | 9 | 83 | 2 | PS51507 | |
| Domain | Cation_ATPase_N | 2.85e-03 | 18 | 83 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 3.18e-03 | 19 | 83 | 2 | IPR004014 | |
| Domain | CH | 3.74e-03 | 70 | 83 | 3 | PF00307 | |
| Domain | CH | 4.21e-03 | 73 | 83 | 3 | PS50021 | |
| Domain | CH-domain | 4.54e-03 | 75 | 83 | 3 | IPR001715 | |
| Domain | Acetyltransf_1 | 4.65e-03 | 23 | 83 | 2 | PF00583 | |
| Domain | GNAT | 5.48e-03 | 25 | 83 | 2 | PS51186 | |
| Domain | GNAT_dom | 5.48e-03 | 25 | 83 | 2 | IPR000182 | |
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 7822029 | ||
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.80e-07 | 6 | 85 | 3 | 25930072 | |
| Pubmed | 4.62e-07 | 281 | 85 | 8 | 24163370 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LAMB4 PARP4 URB1 RPN1 DISC1 PRMT5 CAMSAP3 TSPYL6 ALB ACVR1B FBXO34 | 1.82e-06 | 736 | 85 | 11 | 29676528 |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 21425081 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 26201719 | ||
| Pubmed | HIRA contributes to zygote formation in mice and is implicated in human 1PN zygote phenotype. | 5.90e-06 | 2 | 85 | 2 | 33835048 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27444640 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9284932 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10934221 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 32210480 | ||
| Pubmed | Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R. | 5.90e-06 | 2 | 85 | 2 | 20609246 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9535825 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10859338 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7507207 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8402903 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16982896 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27693509 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38194130 | ||
| Pubmed | A genome-wide screen identifies IRF2 as a key regulator of caspase-4 in human cells. | 5.90e-06 | 2 | 85 | 2 | 31353801 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 38656880 | ||
| Pubmed | An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids. | 5.90e-06 | 2 | 85 | 2 | 24587343 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24453002 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8617930 | ||
| Pubmed | Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection. | 5.90e-06 | 2 | 85 | 2 | 16894313 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 35997559 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27802168 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 2475256 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36583755 | ||
| Pubmed | The role of interferon regulatory factors in the interferon system and cell growth control. | 5.90e-06 | 2 | 85 | 2 | 9865486 | |
| Pubmed | Interferon regulatory factor 1 inactivation in human cancer. | 5.90e-06 | 2 | 85 | 2 | 29599126 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 29804125 | ||
| Pubmed | The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer. | 5.90e-06 | 2 | 85 | 2 | 24632547 | |
| Pubmed | A diverse range of gene products are effectors of the type I interferon antiviral response. | 9.35e-06 | 17 | 85 | 3 | 21478870 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 30082790 | ||
| Pubmed | IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. | 1.77e-05 | 3 | 85 | 2 | 10415056 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10524230 | ||
| Pubmed | Interaction of checkpoint kinase 1 and the X-linked inhibitor of apoptosis during mitosis. | 1.77e-05 | 3 | 85 | 2 | 14759516 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15226432 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15494505 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7768900 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18084608 | ||
| Pubmed | Characterizing the genetic basis of innate immune response in TLR4-activated human monocytes. | 1.77e-05 | 3 | 85 | 2 | 25327457 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31150153 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17177148 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 34476262 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12537697 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10196224 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7650042 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15560761 | ||
| Pubmed | DISC1 complexes with TRAK1 and Miro1 to modulate anterograde axonal mitochondrial trafficking. | 1.77e-05 | 3 | 85 | 2 | 24092329 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 32377817 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 33556340 | ||
| Pubmed | The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. | 1.77e-05 | 3 | 85 | 2 | 11313276 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 27752141 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 28074910 | ||
| Pubmed | 2.75e-05 | 24 | 85 | 3 | 32212159 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 2111015 | ||
| Pubmed | CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling. | 3.53e-05 | 4 | 85 | 2 | 27685627 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 11304541 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 22401310 | ||
| Pubmed | Amino acid deprivation links BLIMP-1 to the immunomodulatory enzyme indoleamine 2,3-dioxygenase. | 3.53e-05 | 4 | 85 | 2 | 19828629 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 23853092 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 32740454 | ||
| Pubmed | Apolipoprotein L1 is transcriptionally regulated by SP1, IRF1 and IRF2 in hepatoma cells. | 3.53e-05 | 4 | 85 | 2 | 32671843 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15778351 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12960317 | ||
| Pubmed | UBE3A regulates the transcription of IRF, an antiviral immunity. | 3.53e-05 | 4 | 85 | 2 | 30690483 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12479817 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 7843405 | ||
| Pubmed | Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. | 3.53e-05 | 4 | 85 | 2 | 21807893 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 29059701 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 21414300 | ||
| Pubmed | The H3.3 chaperone Hira complex orchestrates oocyte developmental competence. | 3.53e-05 | 4 | 85 | 2 | 35112132 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10022868 | ||
| Pubmed | URB1 SCCPDH RPN1 ST7 PRMT5 UFD1 POLRMT IRF2 CTBP1 CABIN1 NCAPH MX1 HIRA | 4.58e-05 | 1440 | 85 | 13 | 30833792 | |
| Pubmed | Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1. | 5.87e-05 | 5 | 85 | 2 | 18955028 | |
| Pubmed | Identification of novel co-repressor molecules for Interferon Regulatory Factor-2. | 5.87e-05 | 5 | 85 | 2 | 12799427 | |
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10764811 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 10364426 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 9865487 | ||
| Pubmed | 5.87e-05 | 5 | 85 | 2 | 11804793 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VANGL2 KIDINS220 FBXO3 RPN1 MACF1 DIDO1 CTBP1 NAA40 ALB ZMYM3 HIRA | 6.54e-05 | 1082 | 85 | 11 | 38697112 |
| Pubmed | 7.60e-05 | 418 | 85 | 7 | 34709266 | ||
| Pubmed | Expression of the Bcl-2 protein BAD promotes prostate cancer growth. | 7.98e-05 | 34 | 85 | 3 | 19593445 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 22042864 | ||
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 11859135 | ||
| Pubmed | RBP-Jkappa/SHARP recruits CtIP/CtBP corepressors to silence Notch target genes. | 8.80e-05 | 6 | 85 | 2 | 16287852 | |
| Pubmed | 8.80e-05 | 6 | 85 | 2 | 28970238 | ||
| Pubmed | 1.20e-04 | 777 | 85 | 9 | 35844135 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 29330412 | ||
| Pubmed | EXD2 promotes homologous recombination by facilitating DNA end resection. | 1.23e-04 | 7 | 85 | 2 | 26807646 | |
| Pubmed | HIRA and Daxx constitute two independent histone H3.3-containing predeposition complexes. | 1.23e-04 | 7 | 85 | 2 | 21047901 | |
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 25596276 | ||
| Pubmed | 1.23e-04 | 7 | 85 | 2 | 15485929 | ||
| Pubmed | 1.42e-04 | 202 | 85 | 5 | 24639526 | ||
| Pubmed | 1.62e-04 | 43 | 85 | 3 | 30733279 | ||
| Pubmed | 1.64e-04 | 8 | 85 | 2 | 11959865 | ||
| Pubmed | ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. | 1.64e-04 | 8 | 85 | 2 | 25086746 | |
| Interaction | HECW2 interactions | 7.07e-06 | 322 | 83 | 9 | int:HECW2 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.10e-07 | 199 | 85 | 7 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 1.10e-07 | 199 | 85 | 7 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.79e-07 | 169 | 85 | 6 | a949f547b53126a208819bade74a1ac9b2a36ea7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.79e-07 | 169 | 85 | 6 | 195d5cd60d646ac6d40a3321b2f739917e7aef14 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.08e-06 | 175 | 85 | 6 | 89bf89466191da14896ed8928027f5b911436c22 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-06 | 175 | 85 | 6 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-06 | 184 | 85 | 6 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-06 | 184 | 85 | 6 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-06 | 189 | 85 | 6 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.79e-06 | 191 | 85 | 6 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.96e-06 | 194 | 85 | 6 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-06 | 194 | 85 | 6 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.96e-06 | 194 | 85 | 6 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-06 | 194 | 85 | 6 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.02e-06 | 195 | 85 | 6 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.02e-06 | 195 | 85 | 6 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.02e-06 | 195 | 85 | 6 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 2.02e-06 | 195 | 85 | 6 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-06 | 196 | 85 | 6 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-06 | 196 | 85 | 6 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 2.08e-06 | 196 | 85 | 6 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 196 | 85 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.08e-06 | 196 | 85 | 6 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 196 | 85 | 6 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.08e-06 | 196 | 85 | 6 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-06 | 196 | 85 | 6 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.08e-06 | 196 | 85 | 6 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.08e-06 | 196 | 85 | 6 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | Control-T/NK_proliferative|Control / Disease condition and Cell class | 2.08e-06 | 196 | 85 | 6 | 7b7bc25aef49bfd64f79303a92d527bf8188f7a6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.14e-06 | 197 | 85 | 6 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 2.14e-06 | 197 | 85 | 6 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | Healthy_Control-Lymphoid-T-Proliferating_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 2.14e-06 | 197 | 85 | 6 | 3ce3dcbbe0edeb5a6fb5596dd6c2b4d6c1d5159d | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.21e-06 | 198 | 85 | 6 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.21e-06 | 198 | 85 | 6 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 199 | 85 | 6 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 2.27e-06 | 199 | 85 | 6 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.27e-06 | 199 | 85 | 6 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-06 | 199 | 85 | 6 | c6d59ed26eadd3c41acfe1b4d929270e00ea3e95 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 199 | 85 | 6 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.27e-06 | 199 | 85 | 6 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 2.27e-06 | 199 | 85 | 6 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.27e-06 | 199 | 85 | 6 | 8ee3dbc0a92de5f3865e5484970ae2aab7d1a956 | |
| ToppCell | Mild-T/NK_proliferative|Mild / Disease group and Cell class | 2.27e-06 | 199 | 85 | 6 | 64a5c91243ee999ea21ffddd450d3e5fdbf6470b | |
| ToppCell | TCGA-Bladder-Primary_Tumor|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.27e-06 | 199 | 85 | 6 | c403e28def2e14f5931cd73b4fb9a4078c0439f8 | |
| ToppCell | distal-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.34e-06 | 200 | 85 | 6 | 0cd3b01fb7f579e5abf000adb8ec8adc7cd779c4 | |
| ToppCell | Biopsy_IPF-Epithelial-Proliferating_Epithelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 2.34e-06 | 200 | 85 | 6 | 63c5402f050fdb12abab3c8b7f33d4914ae26b9b | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-06 | 200 | 85 | 6 | 87e293c0882e2754756a2210a6c04723dc89f81b | |
| ToppCell | PSB-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-06 | 200 | 85 | 6 | 3e3de496508efb2f95e5e8684f97687381e96493 | |
| ToppCell | LAM-Myeloid-pMacrophage|LAM / Condition, Lineage and Cell class | 2.34e-06 | 200 | 85 | 6 | 7e233d037165c9d3607604aaaf0f368e266567d3 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 2.34e-06 | 200 | 85 | 6 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.34e-06 | 200 | 85 | 6 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 2.34e-06 | 200 | 85 | 6 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.34e-06 | 200 | 85 | 6 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-06 | 200 | 85 | 6 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | critical-Lymphoid-NKT-proliferating|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.34e-06 | 200 | 85 | 6 | d698458b90bf8256fe664618ef27620aa910b02a | |
| ToppCell | (18)_cycling_gd_T|World / shred on Cell_type and subtype | 2.55e-06 | 203 | 85 | 6 | 7d58929058c4769226a29febee1fd8ba64bc9f1a | |
| ToppCell | Club_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 3.43e-06 | 120 | 85 | 5 | 7f85208f0455f3e634f8e7e81beea60b4ef1d2a5 | |
| ToppCell | COVID-19-APC-like-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 1.23e-05 | 156 | 85 | 5 | 735ade77cfa16b9386a0c7ec2bd14bd2e78a51ad | |
| ToppCell | droplet-Lung-nan-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 158 | 85 | 5 | ee8ce3cd202807df692b28bb1a81827d49d73862 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-05 | 164 | 85 | 5 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-05 | 169 | 85 | 5 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 169 | 85 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 172 | 85 | 5 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 175 | 85 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 175 | 85 | 5 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.14e-05 | 175 | 85 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 177 | 85 | 5 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-05 | 177 | 85 | 5 | cbedac0bddb8fc330a464815c905928c553b0fc0 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.33e-05 | 178 | 85 | 5 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.33e-05 | 178 | 85 | 5 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.39e-05 | 179 | 85 | 5 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.45e-05 | 180 | 85 | 5 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.52e-05 | 181 | 85 | 5 | 73b1b59810f60e3e39ca1d5073a5a0d4f5377e6e | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 181 | 85 | 5 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-05 | 181 | 85 | 5 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 2.59e-05 | 182 | 85 | 5 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | CV-Severe-3|CV / Virus stimulation, Condition and Cluster | 2.73e-05 | 184 | 85 | 5 | 1c9bda00bb6efd98f68781ca06655bf6c4282f27 | |
| ToppCell | IIF-Lymphocyte-T_NK-T_NK_proliferative|IIF / Disease, Lineage and Cell Type | 2.73e-05 | 184 | 85 | 5 | ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1 | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 2.80e-05 | 185 | 85 | 5 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 3.02e-05 | 188 | 85 | 5 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.02e-05 | 188 | 85 | 5 | 723348a1836a074e068320cb736ce6a953e0038f | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-Cycling_Dendritic|Lung / Manually curated celltypes from each tissue | 3.02e-05 | 188 | 85 | 5 | 0e8ac42c439f30a05e015210e1d5c2dcb9d9d471 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.10e-05 | 189 | 85 | 5 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type | 3.10e-05 | 189 | 85 | 5 | 6339b6d1056e07cefb0e1b2a0e479913c5783c8a | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 3.10e-05 | 189 | 85 | 5 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 3.18e-05 | 190 | 85 | 5 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 3.18e-05 | 190 | 85 | 5 | 451eaceb0cb0ec6cfcae00253c0e5c92a168c2f3 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-05 | 191 | 85 | 5 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.26e-05 | 191 | 85 | 5 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-05 | 191 | 85 | 5 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.26e-05 | 191 | 85 | 5 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 3.26e-05 | 191 | 85 | 5 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.26e-05 | 191 | 85 | 5 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-05 | 191 | 85 | 5 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.26e-05 | 191 | 85 | 5 | 56b45259dfc38bd5ea43b0e3adf47e7e2c043a5d | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.26e-05 | 191 | 85 | 5 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 3.42e-05 | 193 | 85 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 7.29e-06 | 200 | 81 | 7 | 5750_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 7.29e-06 | 200 | 81 | 7 | 6502_UP | |
| Disease | renal overload-type gout | 1.11e-04 | 6 | 81 | 2 | EFO_0021525 | |
| Disease | eosinophil cationic protein measurement | 2.06e-04 | 8 | 81 | 2 | EFO_0010913 | |
| Disease | Leydig cell tumor (is_marker_for) | 2.06e-04 | 8 | 81 | 2 | DOID:2696 (is_marker_for) | |
| Disease | 22q11 partial monosomy syndrome | 2.65e-04 | 9 | 81 | 2 | C3266101 | |
| Disease | longitudinal alcohol consumption measurement | 2.65e-04 | 9 | 81 | 2 | EFO_0007645 | |
| Disease | Asymmetric crying face association | 3.30e-04 | 10 | 81 | 2 | C0431406 | |
| Disease | 22q11 Deletion Syndrome | 3.30e-04 | 10 | 81 | 2 | C2936346 | |
| Disease | Fibrosis | 3.56e-04 | 50 | 81 | 3 | C0016059 | |
| Disease | Cirrhosis | 3.56e-04 | 50 | 81 | 3 | C1623038 | |
| Disease | Liver carcinoma | 4.93e-04 | 507 | 81 | 7 | C2239176 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 5.69e-04 | 13 | 81 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | DiGeorge Syndrome | 8.71e-04 | 16 | 81 | 2 | C0012236 | |
| Disease | amygdala volume change measurement | 8.71e-04 | 16 | 81 | 2 | EFO_0021490 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 8.71e-04 | 16 | 81 | 2 | C0795907 | |
| Disease | Shprintzen syndrome | 8.71e-04 | 16 | 81 | 2 | C0220704 | |
| Disease | sinusitis (is_marker_for) | 1.11e-03 | 18 | 81 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | Lung Injury | 1.51e-03 | 21 | 81 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 1.51e-03 | 21 | 81 | 2 | C2350344 | |
| Disease | Seckel syndrome | 1.66e-03 | 22 | 81 | 2 | C0265202 | |
| Disease | hematocrit | 1.80e-03 | 1011 | 81 | 9 | EFO_0004348 | |
| Disease | physical activity | 1.85e-03 | 88 | 81 | 3 | EFO_0003940 | |
| Disease | necrotizing enterocolitis | 2.50e-03 | 27 | 81 | 2 | EFO_0003928 | |
| Disease | alpha fetoprotein measurement | 2.66e-03 | 100 | 81 | 3 | EFO_0010583 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IAKDMEDSVPLDCSR | 91 | Q9ULK5 | |
| SMCITKPEVDFAVEV | 486 | Q9BYV1 | |
| MAAAAAETPEVLREC | 1 | Q9NXW9 | |
| VKRISEARECENMFP | 391 | F5H4B4 | |
| REMKCLDANEAEPVF | 1211 | P04920 | |
| EAKRMPCAEDYLSVV | 466 | P02768 | |
| RDCTVEMPILKDVAT | 36 | Q13363 | |
| EMPILKDVATVAFCD | 41 | Q13363 | |
| EMFPVACRETTARVK | 631 | Q8NI51 | |
| ADMPAEEREKKLASC | 821 | Q99708 | |
| MDKENRPEAVKSCEA | 226 | Q96M83 | |
| AVKIVDMKRAVDCPE | 36 | O14757 | |
| RVDDTLIPCKANDTM | 546 | Q9UKQ2 | |
| SDPSIEEMRKVVCDQ | 436 | P36896 | |
| PVRVLDMVAKLESEC | 276 | Q9NWN3 | |
| VSERKPALSMEVACA | 466 | Q9H211 | |
| APELAVKEMERCVKE | 121 | Q8TDX5 | |
| LCAAVVKPDVLETMA | 816 | Q8WZ64 | |
| IKPDIMAVSTACEEI | 816 | Q9NSV4 | |
| KLVTDCVAAMNPDAV | 201 | O95861 | |
| RLEEVCLKDPMSVAD | 251 | Q9P1Y5 | |
| PAKEAGEREAAASCM | 831 | Q9NRI5 | |
| FAEIENCSSRMVVPK | 211 | Q96B67 | |
| PRKEDMELDDCSKFV | 571 | Q93084 | |
| MKRTKCADIDVETPD | 261 | Q76L83 | |
| ICKEFADLMAQDRSP | 351 | Q6VUC0 | |
| TMADRAAAERACKDP | 81 | Q9H0Z9 | |
| RALAVDPTEFACMKA | 311 | Q9Y5X4 | |
| FRCAMNSLPDIEEVK | 81 | P10914 | |
| FRCAMNSLPDIEEVK | 81 | P14316 | |
| QDPIIARMSICSEDK | 1636 | Q9ULH0 | |
| TEKVLSICPKDMRAD | 521 | Q8NCM2 | |
| RIEMSKDALPEKACQ | 311 | Q9UK99 | |
| PAMIAECKTRTEVFE | 91 | P01127 | |
| MDSRIPCLIVAAKSD | 516 | Q8IXI2 | |
| SPEICKMADNLDEFI | 31 | Q1MSJ5 | |
| KESEACMLVFQPDLD | 851 | Q9UKK3 | |
| EAAEMDCLQDPAKLS | 126 | Q02509 | |
| RVAADTVKELMCPEA | 391 | Q86VI3 | |
| LEERAAMDAVCAKVD | 16 | Q86UY6 | |
| MALDEFLVKNDPCRA | 7176 | Q9UPN3 | |
| KEECMKASDADRPCR | 281 | Q86U44 | |
| AAFKMEEDDAPIKRC | 171 | P50876 | |
| PDLSSMTEEEKIVCA | 761 | A2A3N6 | |
| RAEEAVAAVMVASCP | 1306 | Q9UHC9 | |
| FKDMPACQEVALDIR | 1071 | Q9P2D7 | |
| FARMAPEQKTELVCE | 851 | Q9NQ11 | |
| VDIFEVEPSKMCIAS | 3411 | Q4G0P3 | |
| VIDCSMAVQEEAKEP | 826 | Q9Y6J0 | |
| AVDRCPMCSAVIDFK | 216 | Q96P09 | |
| EAKVTVDDLPNRMCA | 1436 | Q9BTC0 | |
| ACREKDRDPEAQFEM | 486 | O14744 | |
| ANMEDKRETLPVCEA | 1201 | A4D0S4 | |
| TAEKEAMCLSAPALA | 666 | P54198 | |
| MELASRVCVVSVEKP | 406 | O00411 | |
| EALPDVSRAKSDMAV | 286 | Q5SV97 | |
| DVDAICEMPSLSRKN | 351 | Q2NKX8 | |
| DCTVLPEMKEIVSRD | 1276 | Q5THK1 | |
| LERVCSVMPASITKE | 321 | Q6NUJ1 | |
| SELRAMAKAAREECP | 101 | Q9NQ88 | |
| PRKLCLMEEAVSEFE | 846 | B4DYI2 | |
| ICDIANPASLDEMAK | 76 | Q8NBX0 | |
| PRKLCLMEEVVSEFE | 996 | Q5VVP1 | |
| AVAEAACPGITDKMV | 386 | Q9P289 | |
| MEAKVRVLDPDVCNS | 176 | Q6UWY2 | |
| DPAAEARMKVACITE | 466 | P04843 | |
| MAKFVIRPATAADCS | 1 | P21673 | |
| DPRKLCLMEEAVSEF | 851 | P0DKV0 | |
| CKSIFMRVEDELEIP | 561 | Q9NRC1 | |
| PESADMDVVLESLKC | 106 | Q9NPQ8 | |
| LTHVRMVCEAADDAP | 2236 | O60287 | |
| NVPMCKAADVTAVEV | 231 | Q9BYC2 | |
| DVKSTMLPAAVRCSE | 896 | O94855 | |
| SDNMIRITAVCKVPD | 566 | Q08188 | |
| NVSEADRKCEIDPMF | 231 | Q15003 | |
| DRKCEIDPMFQKTAA | 236 | Q15003 | |
| RKLCLMEEVVSEFEP | 1001 | Q5VYP0 | |
| AVISDRAPKCAVMSD | 1141 | Q96PX9 | |
| RAPKCAVMSDRVPDS | 1146 | Q96PX9 | |
| ARAPECMALKADVVA | 341 | Q96SB8 | |
| RPDISKVNPSDCVDM | 3661 | Q86WI1 | |
| ANEGECRKDVEMEPV | 1201 | Q13464 | |
| LPSREAAEVLKDCIM | 1136 | O60290 | |
| AAEVLKDCIMEPPER | 1141 | O60290 | |
| PDKAVSIIECDMNVD | 176 | Q92890 | |
| KAEDVKPEECAMFSA | 146 | Q8N831 | |
| LVEVERMECATPSDK | 601 | O00206 | |
| PMRIKEDILACSAAE | 1096 | Q14202 | |
| VEGKAEPAMRKDDVC | 111 | Q6F5E7 | |
| MVVSEVDIAKADPAA | 1 | P20591 |